What does CUSIP 867328900 represent in this 13F holders report?

CUSIP 867328900 is the security identifier for 867328900 - SUNESIS PHARMACEUTICALS INC - COM - Call used to aggregate holder disclosures.

How many institutions held 867328900 - SUNESIS PHARMACEUTICALS INC - COM - Call in Q3 2020?

No institutional holders were reported for 867328900 - SUNESIS PHARMACEUTICALS INC - COM - Call in Q3 2020; review adjacent reporting periods for trend context.

SUNESIS PHARMACEUTICALS INC - COM - Call

CUSIP: 867328900

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / COM
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 867328900?
CUSIP 867328900 identifies 867328900 - SUNESIS PHARMACEUTICALS INC - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2020

Recent filing periods for CUSIP 867328900:

Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018

SUNESIS PHARMACEUTICALS INC - COM - Call

Q3 2020 13F Holders as of 30 Sep 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of SUNESIS PHARMACEUTICALS INC - COM - Call as of Q3 2020.